Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2003
10/01/2003EP1347744A1 Solid dispersions of nitrate active principles
10/01/2003EP1347743A2 Composition for treatment of inflammatory disorders
10/01/2003EP1347742A1 Sustained release drug delivery devices with prefabricated permeable plugs
10/01/2003EP1347741A2 Sustained release drug delivery devices with multiple agents
10/01/2003EP1347679A1 Method of inactivating viral particles in a blood product
10/01/2003EP1237854B1 Comminuted form of (s)-2-ethoxy -3- 4-(2- 4-methanesulfonyloxyphenyl ethoxy) phenyl] propanoic acid
10/01/2003EP1202996B1 Titanium derived compounds, preparation and use thereof
10/01/2003EP1097712B1 Steroid-containing cataplasms and process for producing the same
10/01/2003EP1089996B1 Paroxetine methanesulfonate acetonitrile solvate 1:1
10/01/2003EP1056467B1 Method for the treatment of diseases or disorders of the inner ear
10/01/2003EP1051190B1 Vaccine compositions for mucosal administration comprising chitosan and influenza antigen(s)
10/01/2003EP1037666B1 Method for enhancing the absorption and transport of lipid soluble compounds using structured glycerides
10/01/2003EP0999854B1 Switchable viscoelastic systems containing galactomannan polymers and borate
10/01/2003EP0999825B1 Ophthalmic compositions containing galactomannan polymers and borate
10/01/2003EP0998266B1 Microcrystalline cellulose: alginate pharmaceutical suspensions
10/01/2003EP0915693B1 An oil-in-water emulsion for use on human skin for cleansing, preserving or improving the condition of the skin
10/01/2003EP0914098B1 Multi-layered osmotic device
10/01/2003EP0914043B1 Implantable agarose-collagen beads containing cells which produce a diffusible biological product, and uses thereof
10/01/2003EP0904056B1 Process and device for inhalation of particulate medicaments
10/01/2003EP0840597B1 Hydrogel patch
10/01/2003EP0838010B1 High pressure gas exchanger
10/01/2003EP0833606B1 Stable hydroalcoholic compositions
10/01/2003EP0814780B1 Diltiazem controlled release formulation
10/01/2003EP0810854B1 Aerosols containing beclomethazone nanoparticle dispersions
10/01/2003EP0804153B1 Composition comprising a tissue glue and an immobilised therapeutic particle
10/01/2003CN2576229Y Air-permeable wound adhesive-band
10/01/2003CN1446261A Modified cytokines for use in cancer therapy
10/01/2003CN1446128A Compositions inchuding ammonia oxidizing bacteria to increase production of nitric oxide and nitric oxide precursors and methods of using same
10/01/2003CN1446120A Novel microcapsules
10/01/2003CN1446111A Microencapsulated fragrances and methods of coating microcapsules
10/01/2003CN1446103A Treating endotoxemia and related disorders with probiotics
10/01/2003CN1446095A Animal papilla disinfectants and method for improving microbial environment which harmful to animal
10/01/2003CN1446092A Aqueous pharmaceutical compositions
10/01/2003CN1446089A Pharmaceutical composition containing citalopram
10/01/2003CN1446086A Use of estramustine phosphate in treatment of bone metastasis
10/01/2003CN1446083A Coated medicament forms with controlled active substance rdease
10/01/2003CN1446082A ÔÇ£Slow releaseÔÇØ pharmaceutical compositions comprising lithium carbonate
10/01/2003CN1446081A 神经毒素植入物 Neurotoxin implants
10/01/2003CN1446080A Liposomal benzoquinazoline thymidylate synthase inhibitor formulations
10/01/2003CN1446079A Liposomal antineoplastic drugs and uses thereof
10/01/2003CN1446077A Inhaleable spray dried 4-holix bundle protein powders having minimized aggregation
10/01/2003CN1444993A Application of the recombination human interferon omega in preparing medicine for preventing and treating not typical model pneumonia
10/01/2003CN1444989A Application of eupatorium for preparing medicine to prevent and treat serious acute respiratory syndrome (SARS)
10/01/2003CN1444988A External plaster of sea horse and soft-shelled turtle
10/01/2003CN1444983A Ankangxin capsule
10/01/2003CN1444982A Compound preparation of Chinese herbal medicine for treating damp-heat from the lower-jiao and its preparing technique
10/01/2003CN1444974A Capsule with high cellulose for expelling of toxin and nourishing skin as well as its manufacturing methods
10/01/2003CN1444970A Soft capsule of forsythia fruit oil
10/01/2003CN1444969A Plaster for treating pain in neck, shoulder, waist and lower extremities
10/01/2003CN1444964A Application of ÔÇÿWurenchunÔÇÖ capsule for preparing medicine of treating sleep disorder
10/01/2003CN1444951A Exterior Chinese medicine Oil-in-Water (O/W) type prescription for reduce swelling and ease pain and its preparing method
10/01/2003CN1444950A Technique for preparing granules of ÔÇÿfrog oilÔÇÖ"
10/01/2003CN1444947A Breviscapine drop pills and its preparing method
10/01/2003CN1444946A Method for preparing nano-microballons of Avermectins medicine and usage
10/01/2003CN1444945A Medicine containing fritillary total alkali for treating disease of respiratory system and its preparing method
10/01/2003CN1444944A Cyclovirobuxinum D. drop pills and its preparing method
10/01/2003CN1444943A Pentoxifylline tablet controlled relasease tablet
10/01/2003CN1444940A Cresol powder with dissolution increased and its preparing method-analgesic, antipyretic and anti-inflammatory agent
10/01/2003CN1444938A Metronidazole, Clotrimazole and Chlorhexidime Acetate preparation and its preparing method
10/01/2003CN1444937A Drop pills of andrographolide and its preparing method
10/01/2003CN1444936A Drop pills of ÔÇÿWurenchunÔÇÖ and its preparing method
10/01/2003CN1444933A Ethylenediamine Diaceturate injection
10/01/2003CN1444929A Fibrauretine dispersant tablet and its preparing method
10/01/2003CN1444928A Drop pills of five esters and its preparing method
10/01/2003CN1444927A New method for preparing liposome
10/01/2003CN1444926A Bio-adhesiveness drug release system
10/01/2003CN1444925A Long acting injection containing ethyl cellulose for animal
10/01/2003CN1122657C Colchicine skeleton compounds, their use as medicaments and compounds containing them
10/01/2003CN1122535C Substituted amylose as miatrix for sustained drug release
10/01/2003CN1122534C Method for reducing side effects of drug
10/01/2003CN1122509C Medicinal adhesive plastic for treating hepatism
09/2003
09/30/2003US6627663 Especially medicaments containing verapamil; a lecithin/isopropyl myristate solution; butylated hydroxy toluene; pluronic F127; an antioxidant agent suspended in a carrier
09/30/2003US6627620 Composition set and kit for use in intraocular surgery
09/30/2003US6627615 Methods and compositions for in vivo gene therapy
09/30/2003US6627603 Controlled release of an active principle contained in a multiple water-in-oil-in-water emulsion characterized in that the multiple emulsion comprises an invert emulsion Ei with an aqueous phase A1 containing at least a hydrophilic active
09/30/2003US6627600 Time-release implant of drug dispersed in biodegradable polymer; shape retention; nonfused; no need for suspending fluid
09/30/2003US6627422 Non-degradable monofilaments; cylinders; use for implantations and treatment of diabetes, haemophilia, anemia, thalassemia, Parkinson's disease and amyotropic lateral sclerosis
09/30/2003US6627393 Solutions for use as plasma expanders and substitutes
09/30/2003US6627234 Method of producing active agent coated chewing gum products
09/30/2003US6627231 Protecting cell from damage caused by free radicals by administering lipophilic antioxidant comprising vitamin E, beta carotene, extract of Lycopersicum esculentum, hydrophilic antioxidant comprising vitamin c, extract of vitis vinifera
09/30/2003US6627228 Polymeric delivery agents and delivery agents compounds
09/30/2003US6627227 Use of saw palmetto to prevent atherosclerosis
09/30/2003US6627226 Dry solid medium for storage and analysis of genetic material
09/30/2003US6627225 Gellan gum tablet coating
09/30/2003US6627224 Low dose entecavir formulation and use
09/30/2003US6627223 Timed pulsatile drug delivery systems
09/30/2003US6627222 Amoxicillin-dicloxacillin antibiotic composition
09/30/2003US6627221 Unit dose containing less than 5% by weight of stearic acid lubricant in the outer phase, relative to the total weight have good dissolution rate, heat resistance and storage stability for drugs such as ibandronate sodium
09/30/2003US6627220 Tablets containing heat sensitive materials and method for forming thereof
09/30/2003US6627219 Oily capsule preparation and the method for preparing same
09/30/2003US6627218 Cationic lipid with a lipophilic group derived from cholesterol; an amide or carbamate linker bond; an alkylene spacer arm; and a cationic primary, secondary, tertiary or quaternary amino group. facilitating nucleic acid transfer
09/30/2003US6627217 External preparation
09/30/2003US6627216 Liquid composition
09/30/2003US6627215 Devices for improved wound management
09/30/2003US6627214 Adding fumaric acid to reduce throat burn sensation
09/30/2003US6627212 Containing titanium dioxide platelets
09/30/2003US6627211 Vehicle containing alcohol, glycol and biological surfactant
09/30/2003US6627210 Alpha-2-adrenergic agonist component is selected from the group consisting of imino-imidazolines, imidazolines, imidazoles, azepines, thiazines, oxazolines, guanidines, catecholamines and derivatives or mixtures
09/30/2003US6627209 Implanting stent having biodegradable carrier coating and calcium channel blocker
09/30/2003US6627206 Method and apparatus for treating obesity and for delivering time-released medicaments